AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme

Overview of attention for article published in Advances in Therapy, March 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 164 Dimensions

Readers on

mendeley: 151 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Diagnostic methods and compositions for treatment of glioblastoma

Grant US-10456470-B2

United States of America

COMBINATION THERAPY FOR THE TREATMENT OF GLIOBLASTOMA

Grant EP-3038647-B1

European Patent Office

Method of treatment for glioblastoma by administering a VEGF antagonist

Grant US-10208355-B2

United States of America

COMBINATION THERAPY FOR THE TREATMENT OF GLIOBLASTOMA

Grant EP-2882454-B1

European Patent Office